
US Storm Continues To Sweep Through Swiss Stock Market
- Français fr La tempête venue des USA continue de balayer la Bourse suisse Original Read more: La tempête venue des USA continue de balayer la Bourse suiss
+Get the most important news from Switzerland in your inbox
On the other side of the Atlantic, Trump's trade policy continued to disrupt stock markets. On Monday, the Republican president criticised the United States' economic partners for“plundering” it. He described China as“the biggest profiteer of all”.
Meanwhile, the European Union was trying to agree on a response. European foreign trade ministers met in Luxembourg on Monday to“prepare” a joint response to the US measures, a“paradigm shift” to which the EU must adapt, according to the European Commissioner for Trade.
The EU has offered the United States a total and reciprocal exemption from customs duties for industrial products, in an attempt to avoid a trade war, Ursula von der Leyen told a press conference in Brussels.
+ US tariff shock: adding up the Swiss bill
Tariffs will“probably increase inflation” and“slow growth” in the United States, warned the head of the major US bank JPMorgan Chase on Monday in his annual letter to investors.
Jan Viebig, investment director at Oddo BHF SE, agreed.“The political ideas of the new US president Donald Trump are unsettling market participants. This has reinforced the signs of an economic slowdown that were already evident in the US in the final weeks of 2024. The broad S&P 500 stock index has lost around 8.3% since the start of 2025,” he wrote.
On Wall Street, the indices were heading for a red opening. Dow Jones, S&P 500 and Nasdaq futures lost 2.07%, 2.27% and 2.38% respectively.
Swiss stocksAt around 3pm, the SMI was down 4.80% at 11,084.66 points. The SLI was down 4.90% at 1,774.88 points, while the SPI was down 4.53% at 14,851.77 points. All 30 leading stocks were in the red.
Lindt (-1.0%) was the share to lose the least ground, ahead of Sonova (-2.1%) and Schindler (-2.2%).
Logitech (-3.7%) was not spared by the massive sell-off, its production in China being particularly affected by the new taxes imposed by Washington.
The three heavyweights Nestlé (-3.9%), Novartis (-4.6%) and Roche (-5.6%) were unable to reverse the trend.
+ Swiss president warns against tariff 'alarmism'
Swiss Re (-4.9%) was also struggling. GAM (+0.1%) and the reinsurer announced an investment partnership to issue catastrophe bonds and insurance certificates.
Julius Bär was also down (-5.5%). The Zurich-based asset manager is continuing the organisational transformation launched in February under the leadership of new CEO Stefan Bollinger. This includes the creation of a subdivision of the new Global Wealth Management committee, called Global Products and Solution.
Swiss Life (-5.9%), Sika (-6.1%) and Adecco (-7.8%) fell to the bottom of the rankings.
Partners Group (-8.6%) was the worst performer.
The mood on the broader market was also gloomy. Chemical-pharmaceutical stocks, which were still in the red, recovered slightly: Relief Therapeutics (-6.6%), Dottikon (-3.5%) and Xlife Science (-7.8%).
Finally, Dormakaba (-3.4%) was also down. The Zurich-based security access specialist has agreed to form a joint venture with Chinese construction equipment manufacturer Guangdong Kinlong Hardware Products.
Translated from French by DeepL/ts
How we workWe select the most relevant news for an international audience and use automatic translation tools such as DeepL to translate them into English. A journalist then briefly reviews the translation for clarity and accuracy before publication. Providing you with automatically translated news gives us the time to write more in-depth articles. The news stories we select have been written and carefully fact-checked by an external editorial team.
Did you find this explanation helpful? Please fill out the short survey on this page to help us understand your needs.
Popular Stories More Swiss Abroad Why Switzerland hasn't got a capital city Read more: Why Switzerland hasn't got a capital cit
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.
Comments
No comment